Quality of life in insect venom allergic patients
Authors:
- Joanne N.G. Oude ElberinkJEJoanne N.G. Oude Elberink
- Anthony E.J. DuboisADAnthony E.J. Dubois
- 1 August 2003
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Allergy and Clinical Immunology
- Vol. 3 (4) , 287-293
Abstract
As re-sting rates and mortality in Hymenoptera allergy are generally low, health related quality of life is an important therapeutic target in the treatment of allergic patients. This review focuses on the impact of anaphylactic reactions and the effect of interventions in health related quality of life for Hymenoptera allergic patients. Anaphylactic reactions following insect stings can have a great impact on the quality of life of insect sting allergic patients. Venom immunotherapy, with information about the risks and benefits of the treatment, was shown to improve health related quality of life. There were no patients whose health related quality of life was so severely impaired that they did not improve with venom immunotherapy. Treatment with an Epipen (ALK-Abello, Nieuwegein, The Netherlands) resulted in a deterioration in health related quality of life. These findings suggest that patient education of these risks and benefits is as important as the treatment itself in order to achieve all the important therapeutic goals of venom immunotherapy. For most patients the Epipen is insufficient as definitive treatment from a quality of life point of view. Although the low mortality, morbidity and re-sting frequency in Hymenoptera allergic patients has led some authorities to conclude that many patients are treated unnecessarily, this conclusion is refuted by the fact that venom immunotherapy improves health related quality of life in the vast majority of patients receiving this treatment, even if they are not re-stung.Keywords
This publication has 15 references indexed in Scilit:
- Venom immunotherapy improves health-related quality of life in patients allergic to yellow jacket venomJournal of Allergy and Clinical Immunology, 2002
- Development and validation of a health-related quality-of-life questionnaire in patients with yellow jacket allergyJournal of Allergy and Clinical Immunology, 2002
- Debilitating beliefs, emotional distress and quality of life in patients given immunotherapy for insect sting allergyClinical & Experimental Allergy, 1999
- The influence of beliefs on the quality of life of patients with allergic diseasesClinical & Experimental Allergy, 1999
- The discontinuation of Hymenoptera venom immunotherapyJournal of Allergy and Clinical Immunology, 1998
- Discontinuing venom immunotherapy: Outcome after five yearsJournal of Allergy and Clinical Immunology, 1996
- Epidemiology of hymenoptera allergyClinical & Experimental Allergy, 1994
- Decreased Incidence of Stings in Venom-Sensitive Patients Following Venom ImmunotherapyAllergy and Asthma Proceedings, 1994
- Allergists Who Alarm the PublicJAMA, 1980
- Studies of 400 Hymenoptera sting deaths in the United StatesJournal of Allergy and Clinical Immunology, 1973